BRPA Big Rock Partners Acquisition Corp.
Big Rock Partners Acquisition Corp is a blank check company.
On 12/14/2020 the company announced a pending merger wth NueroRX, Inc., a a clinical stage, small molecule pharmaceutical company. NeuroRx develops novel therapeutics for the treatment of COVID-19 (RLF-100 or “ZYESAMI(aviptadil)”) and Bipolar Depression (NRX-100, 101).
$40.26 -2.21 (-5.20%)
As of 02/25/2021 11:29:14 EST IEX book CBOE book
Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Micro cap
Financials
Shell Companies
USA
12/04/2017
2,688,242
63,585
$114,169,638
0.00%
SEC Edgar Online
10-Q
10-K
Common stocks
Micro cap
Financials
Shell Companies
USA
12/04/2017
2,688,242
63,585
$114,169,638
0.00%
SEC Edgar Online
10-Q
10-K
Valuation (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
PB ratio:
PS ratio:
Return on equity:
Net income %:
0.00
35.66
0.00
-0.53%
0.00%
35.66
0.00
-0.53%
0.00%